PROSPECTIVE RANDOMIZED TRIAL COMPARING PEGIFNALPHA 2A AND PEGIFN ALPHA 2B WITH RIBAVIRIN IN HCV-LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C

被引：0
|
作者：
Aguilera, V. [1 ,2 ]
Prieto, M. [1 ,2 ]
Rubin, A. [1 ,2 ]
Risalde, B. [1 ,2 ]
Ortiz Canto, C. [2 ,3 ]
Berenguer, M. [1 ,2 ]
机构：
[1] Hosp Univ La Fe, Serv Hepatogastroenterol, Valencia, Spain
[2] Inst Salud Carlos III, CIBEREHD, Valencia, Spain
[3] Hosp La Fe, Expt Immun Unit, E-46009 Valencia, Spain
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [41] Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
    Neff, GW
    Montalbano, M
    O'Brien, CB
    Nishida, S
    Safdar, K
    Bejarano, PA
    Khaled, AS
    Ruiz, P
    Slapak-Green, G
    Lee, M
    Nery, J
    De Medina, M
    Tzakis, A
    Schiff, ER
    TRANSPLANTATION, 2004, 78 (09) : 1303 - 1307
  • [42] Pharmacotherapy of chronic hepatitis C virus infection - the IDEAL trial: '2b or not 2b (=2a), that is the question'
    Toyoda, Hidenori
    Kumada, Takashi
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (17) : 2845 - 2857
  • [43] Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon α-2b and ribavirin combination after liver transplantation
    Dumortier, J.
    Ducos, E.
    Scoazec, J. -Y.
    Chevallier, P.
    Boillot, O.
    Gagnieu, M. -C.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (08) : 538 - 543
  • [44] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [45] A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C
    Rumi, M
    DelNinno, E
    Parravicini, ML
    Romeo, R
    Soffredini, R
    Donato, MF
    Wilber, J
    Russo, A
    Colombo, M
    HEPATOLOGY, 1996, 24 (06) : 1366 - 1370
  • [46] Impact of pegylated interferon α-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C:: an open-label series
    Mukherjee, Sandeep
    Lyden, Elizabeth
    LIVER INTERNATIONAL, 2006, 26 (05) : 529 - 535
  • [47] Pegylated interferon α-2a and ribavirin combination therapy in HCV liver transplant recipients.: Experience of 7 cases
    Iacob, Speranta
    Gheorghe, Liana
    Hrehoret, Doina
    Becheanu, Gabriel
    Herlea, Vlad
    Popescu, Irinel
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2008, 17 (02) : 165 - 172
  • [48] COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
    Salinas Escudero, G.
    Idrovo, J.
    Rivas, R.
    Ramirez Rodriguez, J.
    Rico Alba, I. A.
    Zapata, L.
    VALUE IN HEALTH, 2009, 12 (03) : A59 - A59
  • [49] Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
    Babatin, M
    Schindel, L
    Burak, KW
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (06) : 359 - 365
  • [50] COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
    Salinas Escudero, G.
    Idrovo, J.
    Rivas, R.
    Ramirez Rodriguez, J.
    Rico Alba, I. A.
    Zapata, L.
    VALUE IN HEALTH, 2009, 12 (07) : A508 - A508
12345